We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Advice and guidance on the health needs of migrant patients for healthcare practitioners
For UKHSA use only: Epidemiological case definitions for CCHF.
Advice for people who have had very close direct contact with someone who has the Marburg virus disease.
Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis in England: national quarterly reports.
Guidance for health professionals to share with pregnant women immunised with COVID-19 vaccines.
The UK government has set regulations to manage the health risks from airborne allergens like mould and pollen, as well as bioaerosols.
The UKHSA real-time syndromic surveillance service monitors seasonal trends of public health and climate conditions.
UKHSA responds to incidents involving non-native or invasive vector species, as well as vector-borne diseases not usually found in the UK. Each incident presents novel vector-borne disease risks and requires entomological ex…
Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis annual data
Guidance on raising performance concerns when a coronavirus (COVID-19) test product is impacted by a variant of concern (VOC) or other emerging variant (V).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).